title: Atrial fibrillation, is warfarin the only option for stroke prevention?
authors.affiliation: International Cerebrovascular Translational Clinical Research and Training Program, Fogarty International Center and National Institutes of Health, USA.
authors.forename: Maria
authors.initials: M
authors.lastname: Khan
authors.forename: Ayeesha Kamran
authors.initials: AK
authors.lastname: Kamal
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000008:administration & dosage; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D001713:Biphenyl Compounds / Q000008:administration & dosage; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D000077144:Clopidogrel; D019317:Evidence-Based Medicine; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000150:complications; D000077405:Irbesartan; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013777:Tetrazoles / Q000008:administration & dosage; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000925:Anticoagulants; D001713:Biphenyl Compounds; D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles; D014859:Warfarin; D000077144:Clopidogrel; D000077405:Irbesartan; D013988:Ticlopidine; D001241:Aspirin